A Birmingham-based digital health start-up which is being supported by WMAHSN was among the creative thinkers whose healthcare innovations may allow us to enjoy longer, more productive lives who were awarded grants of €50,000 recently.
Kaido - one of the start-ups in the Digital Health quarter of the Serendip Smart City Incubator, delivered by Innovation Birmingham in collaboration with WMAHSN as the commercial partner - received the funds to help them turn their brilliant ideas into a commercially viable business at the EIT Health Headstart/Proof-of-Concept Awards.
Kaido’s mission is to empower a consumer-driven approach to health and wellbeing through access to personalised, high-quality educational information.
After 22 finalists pitched their concepts before a jury of experts, Kaido was one of just seven winners chosen to receive in-kind support from IBM, Proctor & Gamble and Pfizer, as well as financial and networking support from EIT Health.
The EIT Health Headstart/Proof-of-Concept Awards in Dublin was organised by the UK/Ireland Co-Location Center of EIT Health. The EIT Health Headstart/Proof-of-Concept Awards programme is an EIT Health Accelerator activity to provide “one-off” funding of up to €50,000 for emerging companies and small and medium sized enterprises (SMEs) to develop new products and services for areas of interest to EIT Health and its members. The purpose of the funding is to accelerate market entry and create new economic activity. This was the first time the EIT Health Headstart/Proof-of-Concept Awards were given out in the British Isles.
Ben Buckley, Sales and Marketing Manager at Kaido, said: "This is a very welcome cash injection but more importantly, gives us a European partner for growth into international markets in the future. This is also sponsored by IBM, Pfizer and Proctor & Gamble, who are interested in speaking to us over coming weeks. Thanks to WMAHSN for being a part of this success and journey."
For more information on Kaido and the other winners, go to the EIT Health website.